The possibility that infectious mononucleosis might be a self-limited form of leukaemia has been raised on a number of occasions (Dameshek and Gunz, 1964) . This speculation has not been supported by studies with the EB virus, the causative agent of infectious mononucleosis, and infections with this virus are not uncommon during the course of acute leukaemia (Stevens et al., 1971) . Nevertheless, the relation of the EB virus to malignant disease and recent reports of infectious mononucleosis being followed closely by leukaemia (Levine et al., 1972) prompted further investigation in this field. . Our observations that in infectious mononucleosis antibodies to a soluble complement-fixing antigen specified by the EB virus develop much later than antibodies to the EB virus capsid antigen (from which it is quite distinct -Marston et al., 1972 ) allow a somewhat more extensive interpretation to be made of serological results than that based upon the estimation of one type of antibody only.
We present the results of investigations in children with acute lymphoblastic leukaemia and with other conditions. The normal responses to infections with common viruses indicate that the humoral immune responses of these patients remained intact, and therefore allow confidence to be placed in the estimates of EB virus antibodies. Methods Sera were obtained from children admitted to hospital with acute lymphoblastic leukaemia, with infectious mononucleosis, and with other conditions. In those with leukaemia the criteria for cytological diagnosis were those of Hayhoe, Quaglino, and Doll (1964) EB CF antibody levels in sera which had been taken from 10 children within 1 month of the onset of leukaemia were compared (Table and Fig.) with those in 39 control patients, in 22 children with acute infectious mononucleosis who were tested within 1 month of onset, and in 12 children who were tested during convalescence after infectious mononucleosis (mean 3 months after onset). Infectious mononucleosis in the past is commonly associated with EB CF antibody levels of greater than about 1/16, and the results in the leukaemic children resembled those in the group with known past infectious mononucleosis and differed significantly from the control group and the group with active infectious mononucleosis.
Development of antibodies to other viruses. The prevalence of cytomegalovirus antibodies in 65 sera from leukaemic patients (17%) resembled that observed by Stern and Elek (1965) serological conversion was asymptomatic. The prevalence of adenovirus antibodies in 65 sera from leukaemic patients (65 %) resembled that in 76 nonleukaemic hospital patients of the same ages (64%). In 7 of 24 patients there was evidence of adenovirus infection, either asymptomatic or associated with mild respiratory illnesses. 4 leukaemic children had measles, 3 had rubella, and 2 had varicella (all confirmed virologically). These infections were uneventful with the exception of a girl of 5 years who succumbed to fulminating haemorrhagic varicella. Hepatitis B antigen was present in 3 of 121 sera from 41 leukaemic children. 26 patients were tested on more than one occasion and 3 became positive 3, 10, and 27 months after the onset of leukaemia; in 1 child, reversion to a negative state occurred. 1 child developed jaundice and ascites shortly after the detection of hepatitis B antigen and in the other 2 infection was apparently asymptomatic.
As a general index of antibody production, total ,gM, IgA, and IgG immunogiobulins were estimated in 12 episodes of infection in leukaemic children: low IgA levels (less than 10% of Medical Research Council standard serum) were observed in 2 patients during cytomegalovirus and adenovirus infections. In 2 other patients, serial tests over about 12 months showed infections with adenovirus and with cytomegalovirus; IgM, IgA, and IgG immunoglobulins were not depressed over this period and there was no evidence that these infections were associated with any humoral immunological deficiency.
Discussion
The development of hepatitis B antigenaemia and of EB CF antibodies during the course of leukaemia was probably related to blood transfusion (Gerber et al., 1969; Kapsenberg et al., 1970) ; the presence of hepatitis B antigen in 7 * 5% of the leukaemic children underlines the potential risks of sera from these patients. Otherwise, the leukaemic children responded to viral infections in a normal fashion.
The presence of EB CF antibodies in children tested within 1 month of the onset of leukaemia was a surprising observation. Their presence was probably not simply related to the effects of lymphoproliferation, for no differences were apparent in incidence or levels of antibodies to EB virus capsid antigen.
EB CF antibodies, which differ in several respects from EB virus capsid antigen antibodies (Marston et al., 1972) , develop regularly after infectious mononucleosis. These CF antibodies develop slowly and, though sometimes detectable in individuals with active infectious mononucleosis, are normally only detectable after some months. Young children, aged 5 years and under, respond to infection with EB virus in much the same way as adults (Sutton et al., 1974) , though in this age group heterophile antibodies are observed only rarely (Vahlquist, Ekelund, and Tveteras, 1958) .
Leukaemic patients often receive blood transfusions, and infection with EB virus may be acquired in this way. However, high levels of EB CF antibody are not found in patients with infectious mononucleosis tested within 1 month of onset and this suggests that the high levels observed in our leukaemic patients tested within 1 month of onset were not associated with such blood transfusions. Indeed, in the leukaemic children tested during the first month of illness, the proportion with CF antibodies resembled that in controls with past infectious mononucleosis who had been tested in convalescence. This suggests that they experienced an asymptomatic EB virus infection some months before their diagnosis. Some recent reports indicate that this may be related to the development of their leukaemia.
The herpes-like EB virus (a DNA virus) is associated with Burkitt's lymphoma (Henle and Henle, 1966) , with nasopharyngeal carcinoma (zur Hausen et al., 1970) , with Hodgkin's disease (Johannsson et al., 1970) , and with infectious mononucleosis (Henle, Henle, and Diehl, 1968; Evans, Niederman, and McCollum, 1968) . However, nucleic acid homologous with that of the RNA Rauscher murine leukaemia virus has been detected in Burkitt's lymphoma and nasopharyngeal carcinoma cells (Kufe, Hehlmann, and Spiegelman, 1973) and in Hodgkin's disease (Hehlmann, Kufe, and Spiegelman, 1972a) . It has also been detected in leukaemic cells (Hehlmann, Kufe, and Spiegelman, 1972b) and antigenic relations have been observed (Mann, Halterman, and Leventhal, 1973) between acute leukaemic cells and cells infected with Rauscher leukaemia virus. Patients with infectious mononucleosis have been known to develop Hodgkin's disease (English, 1970 ), Burkitt's lymphoma (Cohen et al., 1970) , and acute leukaemia (Levine et al., 1972) .
Thus, we have evidence for some kind of link between infectious mononucleosis and malignant disease (if on rare occasions) and apparently conflicting evidence which associates both DNA and RNA viruses with these conditions. These conflicting reports may be reconciled when we consider the ability of the EB virus in infectious mononucleosis to induce a temporary depression of cell-mediated immunity, as indicated by the response to tuberculin (Haider et al., 1973) . This depression of cell-mediated immunity (either as here suggested by EB virus, or by other means) could well be the necessary stimulus required to activate otherwise dormant RNA tumour virus genomes, such as those whose vertical transmission has been shown in mice by Huebner and his colleagues (1970) . Alternatively, some other facet of the complex immunopathology induced by EB virus infection (Lancet, 1973) might be involved. In a different, but analogous, experimental situation such an activation of an endogenous, vertically transmitted, RNA tumour virus by a DNA virus has been demonstrated by Rhim and Huebner (1973) . In man, some indirect evidence exists for the presence of such a vertically transmitted agent, in that raised IgM levels have been detected in neonatal sibs of children with leukaemia (Sutton, Bishun, and Soothill, 1969; Chandra, 1972 
